Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges

Case Reports in Hematology
doi 10.1155/2018/2080185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Advances and Challenges in the Management of Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2015English

Essential Thrombocythemia

New England Journal of Medicine
Medicine
2020English

Essential Thrombocythemia

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2007English

How We Diagnose and Treat Essential Thrombocythaemia

British Journal of Haematology
Hematology
2015English

Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities

Nanomaterials
Materials ScienceChemical Engineering
2018English

Updates in the Management of Polycythemia Vera and Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2019English

Inflammatory Breast Cancer: Clinical Progress and the Main Problems That Must Be Addressed

Breast Cancer Research
Cancer ResearchOncology
2003English

Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy